A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).
Yoshiki ArakawaKeita SasakiYohei MineharuMegumi UtoTakashi MizowakiJunki MizusawaYuta SekinoTomohiro OnoHidefumi AoyamaKaishi SatomiKoichi IchimuraManabu KinoshitaMakoto OhnoYoshinori ItoRyo NishikawaHaruhiko FukudaYasumasa NishimuraYoshitaka Naritanull nullPublished in: BMC cancer (2021)
Registry number: jRCTs031200099 . Date of Registration: 27/Aug/2020. Date of First Participant Enrollment: 4/Sep/2020.